1Antithrombotic Trialists' Collaboration. CoUaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002,324:71-86.
2Amarenco P, Bogousslavsky J, Callahan A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med, 2006,355:549-559.
3Guidelines for prevention of stroke in patients with ischemic stroke transient ischemic attack : a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke, 2006,37:577-617.
4Ovbiagele B, Saver JL, Fredieu A, et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke ,2004,35:2879-2883.
5Koennecke HC. Secondary prevention of stroke: a practical guide to drug treatment. CNS Drugs,2004,18:221-241.
6McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med,2006,119:624-638.
7Gorelick PB, Weisman SM. Risk of hemorrhagic stroke with aspirin use: an update. Stroke, 2005,36:1801-1807.
8Chen ZM, Sandercock P, Pan HC, et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke,2000,31 : 1240-1249.
9He J, Whelton PK, Vu B, et al. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA, 1998,280 : 1930-1935.
10Caplan LR. Thoughts evoked by MATCH and other trials. Stroke, 2004,35:2604-2605.
